Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of Alzhermer's disease

Details for Australian Patent Application No. 2005295814 (hide)

Owner Merck & Co., Inc. Sunesis Pharmaceuticals, Inc.

Inventors Selnick, Harold G.; Rittle, Kenneth E.; Egbertson, Melissa S.; Coburn, Craig A.; Neilson, Lou Anne; Yang, Wenjin; Lu, Wanli; McWherter, Melody A.; McGaughey, Georgia B.; Yang, ZhiQiang; Barrow, James C.; Fahr, Bruce; Stauffer, Shaun R.

Agent Spruson & Ferguson

Pub. Number AU-A-2005295814

PCT Pub. Number WO2006/044497

Priority 60/618,420 13.10.04 US

Filing date 12 October 2005

Wipo publication date 27 April 2006

International Classifications

A61K 31/4747 (2006.01) - spiro-condensed

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/044497 Priority application(s): WO2006/044497

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005295816-Consortium of nitrifying bacteria

2005295811-Adhesive suture structure and methods of using the same